“If” we look like failing to retrieve a sample in M2ST, will the liner be run in before hole deterioration so we can go straight to flow testing in Q1/Q2 without pushing the envelope this time.
Pebbly Arkose - was it sealed and holding reservoir in M1 or residual, and, how does it track over the rest of the field for potential sealed sections.
Does the Exalto rig 202 have the capacity for drilling out the Lower Angwa at a decent gauge in the deeper sections of Mukuyu or will a larger rig be required later on.
Correlation between M1 and M2 with consideration given to mud weight, mud consistency, and mud infiltration of M1, ie do the reservoirs come out about the same when put into context.
Cost of 3D over Mukuyu, (apologies SM has answered this before but can’t find it)
Any firmer timeline for flow testing, what is required to be bought in to facilitate this.
Plans for M3 next or will we head elsewhere.
Again, thanks Matt
- Forums
- ASX - By Stock
- JRI Fireside chat with Scott Macmillan Tues. Nov 28 @ 9:00 Perth/12:00 Sydney
“If” we look like failing to retrieve a sample in M2ST, will the...
-
-
- There are more pages in this discussion • 569 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
0.002(2.94%) |
Mkt cap ! $99.25M |
Open | High | Low | Value | Volume |
6.9¢ | 7.0¢ | 6.7¢ | $101.9K | 1.487M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 354854 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.069 |
5 | 240973 | 0.068 |
5 | 887635 | 0.067 |
7 | 248441 | 0.066 |
6 | 286432 | 0.065 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 354854 | 3 |
0.071 | 5417 | 1 |
0.073 | 325000 | 2 |
0.074 | 200000 | 2 |
0.075 | 737400 | 5 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
IVZ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online